Trials / Unknown
UnknownNCT01726894
Focal Therapy for Localised Prostate Cancer Using Irreversible Electroporation
A Prospective Development Study Evaluating Focal Therapy Using Irreversible Electroporation (Nanoknife®) in Men With Localised Prostate Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- University College London Hospitals · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine the adverse events and genito-urinary side-effect profile of focal therapy to treat localised low to intermediate risk prostate cancer using irreversible electroporation (Nanoknife™).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Irreversible Electroporation |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2015-08-01
- First posted
- 2012-11-15
- Last updated
- 2014-06-18
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01726894. Inclusion in this directory is not an endorsement.